Quick Answer
ROCKET PHARMACEUTICALS, INC. reported Stockholders Equity of $277.22 million for fiscal year 2025.
ROCKET PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $277.22M | -40.2% |
| 2024 | $463.23M | -6.0% |
| 2023 | $492.57M | +0.6% |
| 2022 | $489.69M | +7.7% |
| 2021 | $454.72M | -9.7% |
| 2020 | $503.52M | +63.9% |
| 2019 | $307.30M | +58.4% |
| 2018 | $194.04M | +1150.3% |
| 2017 | $15.52M | +85.4% |
| 2016 | $8.37M | -46.1% |
| 2015 | $15.54M | +130.1% |
| 2014 | -$51.56M | -32.6% |
| 2013 | -$38.90M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $313.67M | -4.9% | -11.4% |
| June 30, 2025 | $354.21M | -7.9% | -14.1% |
| March 31, 2025 | $412.14M | -6.7% | -11.0% |
| December 31, 2024 | $463.23M | -6.0% | +40.5% |
| September 30, 2024 | $329.77M | -39.1% | -14.3% |
| June 30, 2024 | $384.63M | -4.5% | -12.9% |
| March 31, 2024 | $441.50M | -3.8% | -10.4% |
| December 31, 2023 | $492.57M | +0.6% | -9.0% |
- ROCKET PHARMACEUTICALS, INC. showed a decrease of -40.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, ROCKET PHARMACEUTICALS, INC.’s stockholders equity has grown by 812.7% (from -$38.90 million to $277.22 million).
- The most recent figure is from ROCKET PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: